Burke J

No ORCID on file · 4 papers in corpus · active 1985-2014

Study types

  • article 3

Condition tags

  • endometriosis 3
  • chronic_pelvic_pain 2
  • dysmenorrhea 1
  • dyspareunia 1
article 2014
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719114549848

This randomized double-blind study, with 24-week treatment and 24-week posttreatment periods, evaluated the effects of elagolix (150 mg every day, 75 mg twice a day) versus subcutaneous depot medroxyprogesterone acetate (DMPA-SC) on bone mi…

article 2013
Journal of endometriosis and pelvic pain disorders ·doi:10.5301/je.5000157

OBJECTIVE: The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. METHODS: This was a phase II, randomized, placeb…

article 2013
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719113497292

This Phase 2 study evaluated the safety and efficacy of elagolix for treating endometriosis-associated pain. A total of 155 women with laparoscopically confirmed endometriosis were randomized to placebo, elagolix 150 mg, or elagolix 250 mg …

1985
AJR. American journal of roentgenology ·doi:10.2214/ajr.144.1.101

Although adhesive capsulitis of the shoulder is a common clinical syndrome, adhesive capsulitis in other joints has rarely been reported. Four patients who developed adhesive capsulitis of the hip joint after trauma and two patients with ad…